BAT Launches Synthetic Nicotine Vape 'Nomad Sync 5000' in South Korea

Nov.25.2024
BAT Launches Synthetic Nicotine Vape 'Nomad Sync 5000' in South Korea
BAT has launched its synthetic nicotine vape product "Nomad Sync 5000" in South Korea for the first time. The device features 10ml of e-liquid with a nicotine concentration of 0.9%, offering up to 5,000 puffs. It is available in two colors and priced at $12.

British American Tobacco (BAT) will be launching its synthetic nicotine e-cigarette product "Nomad Sync 5000" in the South Korean market for the first time, according to a report by N.News on November 25th.

 

BAT's South Korean subsidiary has revealed that the new e-liquid product has a capacity of 10 milliliters and a nicotine content of 0.9%, allowing for up to 5000 puffs. It comes in two flavors, "Purple" and "Cold," with a suggested retail price of around 17,000 Korean won (12 USD).

 

According to reports, BAT chose to launch "Nomad" in South Korea partly because there is a regulatory gap in the country. Under the current Tobacco Business Act in South Korea, only products made from tobacco leaves are defined as tobacco. Therefore, synthetic nicotine products do not fall under this category and are not subject to related tobacco regulations. As a result, synthetic nicotine products do not have to pay tobacco consumption taxes and other related fees, allowing them to be sold cheaper than traditional tobacco or heated tobacco products. Additionally, selling to minors does not result in penalties, and there is no requirement to include warning labels or images.

 

A company official said: "Despite the absence of specific regulations on synthetic nicotine in South Korea's Tobacco Business Act, we plan to voluntarily comply with the country's domestic tobacco regulations outside of the synthetic nicotine industry norms."

 

"The reason for the launch of South Korea's first synthetic nicotine e-cigarette 'Nomad' is because South Korea is the only OECD country that applies different laws to synthetic nicotine e-cigarettes and natural nicotine e-cigarettes."

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.